US Bancorp
LKFT

US Bancorp’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

US Bancorp’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.32K Sell
144
-38
-21% -$1.26K ﹤0.01% 3619
2025
Q4 		$5.95K Buy
182
+88
+94% +$2.84K ﹤0.01% 3475
2025
Q3 		$3.26K Hold
94
– – ﹤0.01% 3663
2025
Q2 		$2.63K Sell
94
-56
-37% -$1.5K ﹤0.01% 3812
2025
Q1 		$3.77K Sell
150
-159
-51% -$4.02K ﹤0.01% 3734
2024
Q4 		$8.5K Buy
309
+10
+3% +$279 ﹤0.01% 3481
2024
Q3 		$8.61K Sell
299
-91
-23% -$2.48K ﹤0.01% 3413
2024
Q2 		$9.66K Buy
390
+31
+9% +$880 ﹤0.01% 3314
2024
Q1 		$11.6K Sell
359
-462
-56% -$17.2K ﹤0.01% 3287
2023
Q4 		$33.4K Buy
821
+502
+157% +$18.5K ﹤0.01% 2858
2023
Q3 		$11K Sell
319
-397
-55% -$15.5K ﹤0.01% 3136
2023
Q2 		$29.1K Sell
716
-79
-10% -$3.22K ﹤0.01% 2783
2023
Q1 		$30.7K Buy
795
+268
+51% +$11K ﹤0.01% 2763
2022
Q4 		$23.4K Sell
527
-969
-65% -$40.8K ﹤0.01% 2915
2022
Q3 		$64K Sell
1,496
-154
-9% -$7.89K ﹤0.01% 2406
2022
Q2 		$92K Sell
1,650
-946
-36% -$56.1K ﹤0.01% 2280
2022
Q1 		$161K Buy
2,596
+1,182
+84% +$72.3K ﹤0.01% 2054
2021
Q4 		$78K Buy
1,414
+733
+108% +$38.2K ﹤0.01% 2419
2021
Q3 		$36K Sell
681
-664
-49% -$39.4K ﹤0.01% 2814
2021
Q2 		$92K Sell
1,345
-12,711
-90% -$969K ﹤0.01% 2357
2021
Q1 		$1.08M Buy
14,056
+13,702
+3,871% +$1.26M ﹤0.01% 1092
2020
Q4 		$35K Sell
354
-103
-23% -$12.6K ﹤0.01% 2661
2020
Q3 		$65K Sell
457
-62
-12% -$10.3K ﹤0.01% 2283
2020
Q2 		$102K Buy
519
+64
+14% +$13.3K ﹤0.01% 2095
2020
Q1 		$89K Sell
455
-1,504
-77% -$324K ﹤0.01% 2078
2019
Q4 		$405K Buy
1,959
+1,644
+522% +$304K ﹤0.01% 1476
2019
Q3 		$48K Sell
315
-56
-15% -$9.18K ﹤0.01% 2488
2019
Q2 		$48K Sell
371
-24
-6% -$2.85K ﹤0.01% 2542
2019
Q1 		$46K Sell
395
-129
-25% -$13K ﹤0.01% 2523
2018
Q4 		$48K Sell
524
-87
-14% -$8.82K ﹤0.01% 2464
2018
Q3 		$68K Sell
611
-658
-52% -$69.5K ﹤0.01% 2409
2018
Q2 		$117K Sell
1,269
-447
-26% -$43.4K ﹤0.01% 2146
2018
Q1 		$171K Sell
1,716
-785
-31% -$84.6K ﹤0.01% 1956
2017
Q4 		$235K Sell
2,501
-1,341
-35% -$127K ﹤0.01% 1798
2017
Q3 		$391K Sell
3,842
-23,889
-86% -$2.09M ﹤0.01% 1533
2017
Q2 		$2.12M Buy
27,731
+27,714
+163,024% +$2.33M 0.01% 740
2017
Q1 		$1K Sell
17
-25
-60% -$1.8K ﹤0.01% 3467
2016
Q4 		$3K Buy
+42
New +$2.58K ﹤0.01% 3303
2016
Q1 		– Sell
-46
Closed -$3K – 3577
2015
Q4 		$3K Buy
+46
New +$2.35K ﹤0.01% 3349

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

US Bancorp's LKFT Position: Q1 2026 in Review

US Bancorp reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 21% in Q1 2026, selling an estimated $1.26K and leaving 144 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #3619.

US Bancorp first reported a position in LKFT in Q4 2015 and has held it in 39 quarters since. The position peaked at $2.12M in Q2 2017. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • US Bancorp held 144 shares of Lakefront Biotherapeutics American Depositary Shares worth $4.32K as of Q1 2026.
  • US Bancorp sold 38 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $1.26K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3619 holding.
  • US Bancorp first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and has held it in 39 quarters since.
  • US Bancorp's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.12M in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.